LON:BPCR BioPharma Credit Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BioPharma Credit PLC Please log in to your account or sign up in order to add this asset to your watchlist. GBX 0.93 +0.00 (+0.32%) (As of 06/27/2022 12:37 PM ET) Add Compare Share Today's Range 0.92▼ 0.9350-Day Range 0.93▼ 1.0252-Week Range 0.92▼ 1.05Volume3.21 million shsAverage Volume1.97 million shsMarket Capitalization£12.79 millionP/E Ratio15.02Dividend Yield7.54%Price TargetN/A ProfileChartCompetitorsDividendInsider TradesHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive BPCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCR Stock Forecast (MarketRank)Overall MarketRank™1.56 out of 5 starsAnalyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for BioPharma Credit. Previous Next 4.3 Community Rank Outperform VotesBioPharma Credit has received 84 “outperform” votes. (Add your “outperform” vote.)Underperform VotesBioPharma Credit has received 46 “underperform” votes. (Add your “underperform” vote.)Community SentimentBioPharma Credit has received 64.62% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about BioPharma Credit and other stocks. Vote “Outperform” if you believe BPCR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BPCR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipBioPharma Credit is a leading dividend payer. It pays a dividend yield of 7.54%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthBioPharma Credit does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, BioPharma Credit insiders have not sold or bought any company stock. Previous Next 1.9 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of BioPharma Credit is 15.02, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 17.09.Price to Earnings Ratio vs. SectorThe P/E ratio of BioPharma Credit is 15.02, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 22.28.Price to Book Value per Share RatioBioPharma Credit has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About BioPharma CreditBioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.Read More BPCR Stock News HeadlinesJune 23, 2022 | finance.yahoo.comDEM BioPharma Launches with $70 Million FinancingJune 23, 2022 | msn.comDEM BioPharma launches with $70m to take a bite out of cancerMay 12, 2022 | apnews.comABVC BioPharma, Inc. Announces $4.22 Million Registered Direct OfferingApril 20, 2022 | marketwatch.comBioPharma Credit Shareholder to Sell 55 Mln Shares via Bookbuild ProgramMarch 8, 2022 | marketwatch.comBioPharma Credit to Invest Up to $50 Mln in UroGen PharmaFebruary 3, 2022 | lse.co.ukBiopharma Cred. Share ChatSeptember 10, 2021 | marketwatch.comBioPharma Credit to Apply for Admission to Listing on LSE Main Market's Premium SegmentAugust 30, 2021 | proactiveinvestors.comBioPharma Credit PLC - Holding(s) in CompanyJune 25, 2021 | markets.businessinsider.comBioPharma Credit PLC : Result of GM and AGMJune 6, 2021 | markets.businessinsider.comBioPharma Credit PLC : Notice of GM and Change in Proposed AuditorFebruary 1, 2021 | fool.comWhy Matinas BioPharma Stock Crashed TodayJanuary 22, 2021 | msn.comWhy AzurRx BioPharma Is Trading Sharply Higher TodayJanuary 19, 2021 | marketwatch.comScopus BioPharma Announces Completion of Clinical Lot ManufactureSee More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorFinance Current SymbolLON:BPCR CUSIPN/A CIKN/A Webwww.bpcruk.com Phone44 13 9247 7500FaxN/AEmployeesN/AYear FoundedN/ACompany Calendar Ex-Dividend for 3/31 Dividend3/03/2022Dividend Payable3/31/2022Ex-Dividend for 5/31 Dividend5/05/2022Dividend Payable5/31/2022Today6/27/2022Next Earnings (Estimated)9/13/2022Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio15.02 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio16.51 Quick Ratio16.51 Sales & Book Value Annual Sales£103.88 million Price / Sales0.12 Cash FlowGBX 6.75 per share Price / Cash Flow0.14 Book ValueGBX 99.30 per share Price / Book0.01Miscellaneous Outstanding Shares1,373,872,000Free FloatN/AMarket Cap£12.79 million OptionableNot Optionable BetaN/A BioPharma Credit Frequently Asked Questions How has BioPharma Credit's stock performed in 2022? BioPharma Credit's stock was trading at GBX 0.97 at the beginning of 2022. Since then, BPCR stock has decreased by 3.8% and is now trading at GBX 0.93. View the best growth stocks for 2022 here. When is BioPharma Credit's next earnings date? BioPharma Credit is scheduled to release its next quarterly earnings announcement on Tuesday, September 13th 2022. View our earnings forecast for BioPharma Credit. How often does BioPharma Credit pay dividends? What is the dividend yield for BioPharma Credit? BioPharma Credit announced a dividend on Wednesday, April 27th. Shareholders of record on Thursday, May 5th will be paid a dividend of GBX 0.02 per share on Tuesday, May 31st. This represents a yield of 1.76%. The ex-dividend date is Thursday, May 5th. The official announcement can be viewed at this link. View BioPharma Credit's dividend history. Is BioPharma Credit a good dividend stock? BioPharma Credit(LON:BPCR) pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.54%. BPCR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of BioPharma Credit is 112.90%. Payout ratios above 75% are not desirable because they may not be sustainable. View BioPharma Credit's dividend history. Who are BioPharma Credit's key executives? BioPharma Credit's management team includes the following people: Mr. Pedro Gonzalez de Cosio, Investment Mang.Mr. Pablo Gerardo Legorreta, Investment Mang. (Age 57)Mr. Martin G. Friedman, Investment Mang. (Age 57) Who are some of BioPharma Credit's key competitors? Some companies that are related to BioPharma Credit include Gresham House Strategic (GHS), Allied Minds (ALM), Tavistock Investments (TAVI), Big Banc Split (BNK), Wilmington Capital Management (WCM.A), Lighthouse Group (LGT), River and Mercantile Group (RIV), Jupiter Green Investment Trust (JGC), Foresight Solar & Technology VCT (FTSV), Frontier IP Group (FIPP), ScotGems (SGEM), Chelverton UK Dividend Trust (SDV), Triple Point Income VCT (TPVE), Catena Group (CTNA) and Brookfield Select Opportunities Incm Fd (BSO.UN). View all of BPCR's competitors. What other stocks do shareholders of BioPharma Credit own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioPharma Credit investors own include AFPO.L (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), 21512 (SAT.L) (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), Hochschild Mining (HOC), SPX FLOW (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX). What is BioPharma Credit's stock symbol? BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR." How do I buy shares of BioPharma Credit? Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is BioPharma Credit's stock price today? One share of BPCR stock can currently be purchased for approximately GBX 0.93. How much money does BioPharma Credit make? BioPharma Credit (LON:BPCR) has a market capitalization of £12.79 million and generates £103.88 million in revenue each year. How can I contact BioPharma Credit? BioPharma Credit's mailing address is Beaufort HSE, 51 New North Road, EXETER, EX4 4EP, United Kingdom. The official website for BioPharma Credit is www.bpcruk.com. The company can be reached via phone at 44 13 9247 7500. This page (LON:BPCR) was last updated on 6/27/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
